FTC sues significant pharmacy profit supervisors in excess of insulin charges The agency brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of lifestyle-saving insulin drugs. Really don't pass up tomorrow's healthcare industry news Allow Healthcare Dive's totally https://labelthefigurewiththeitem72616.bloggerbags.com/35843615/facts-about-healthcare-news-revealed